SecBot SecBot
144 ·Filed Apr 24, 2026

DYN

Dyne Therapeutics, Inc.
BEARISH
Impact 6/10
Horizondays Processed6mo ago SEC0001628280-26-027252
Actionable Insight ▼ Bearish

Monitor for actual execution of these sales, as the coordinated filing by a major shareholder signals potential lack of confidence. This adds to recent insider selling pressure and could weigh on the stock.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$18.04
T+0 close · Apr 24, 2026 · via day close
Latest settled
+28.66%
T+60 · $23.21
Vs SPY
+23.88%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 27 $18.04entry
  2. T+1 · 7mo ago +0.67%α +1.15% · $18.16
  3. T+5 · 7mo ago −1.83%α −2.23% · $17.71
  4. T+20 · 6mo ago +0.61%α −4.35% · $18.15
  5. T+60 · 4mo ago +28.66%α +23.88% · $23.21
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three institutional investors affiliated with Atlas Venture, Atlas Venture Associates XI, L.P., Atlas Venture Fund XI, L.P., and Atlas Venture Opportunity Fund I, L.P., filed Form 144s to sell up to 1,050,000 shares of Dyne Therapeutics (DYN) each, totaling 3.15 million shares. This represents a coordinated insider sale by a major shareholder group.

Key Facts

  • Three affiliated funds of Atlas Venture each filed to sell up to 1,050,000 shares of DYN
  • Total proposed sale is 3.15 million shares
  • Atlas Venture is a major institutional shareholder
  • Recent insider activity shows $13.4M in sells over the past 30 days

Financial Impact

3.15 million shares, approximately $30.5 million at current $9.70 stock price

dilutioninsider sentiment

Risk Factors

  • Significant insider selling could pressure the stock price
  • Perception of lack of confidence from a major institutional backer

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (DYN), Batch item 10001628280-26-027252
Document: 0001628280-26-027252-index.html0001628280-26-027253
Document: 0001628280-26-027252.txt0001628280-26-027255
144 Filing (DYN), Batch item 40001628280-26-027253
Document: 0001628280-26-027253-index.html0001628280-26-027252
144 Filing (DYN), Batch item 60001628280-26-027255

Track record

54 reports on DYN

Performance horizon

12 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 14 of 15 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens in 9h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026